Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMED: High vs Standard Dose Dexamethasone in COVID-19 ARDS
NCT04663555Phase 4Completed
- Sponsor
- Fakultní nemocnice Brno
- Start
- Feb 2021
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Fakultní nemocnice Brno. Started Feb 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04663555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04663555.